Octreotide
CHEBI:CHEBI_7726
Chemical Information
- Molecular Formula
- C49H66N10O10S2.2C2H4O2
- Molecular Mass
- 1019.24174
- Charge
- 0
- SMILES
- [H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)NC(CO)[C@@H](C)O)NC(=O)[C@H](N)Cc1ccccc1)[C@@H](C)O
- InChI
- InChI=1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64)/t28-,29-,34-,36+,37+,38-,39?,40+,41+,42+/m1/s1
- InChIKey
- DEQANNDTNATYII-FLDZURHUSA-N
Alternative Names
- D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L- cysteinamide cyclic (2->7)-disulfide
- D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
- D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2->7)-disulfide
- Longastatin
- octreotida
- octreotide
- Octreotide
- octreotide acetate
- octreotidum
- sandostatine
- SMS-201-995
Treatment Applications
-
jejunal somatostatinomaView Disease →
DOID:3216
-
somatostatinomaView Disease →
DOID:4430
-
obsolete trabecular adenomaView Disease →
DOID:5400
Drug Classification
-
homodetic cyclic peptideView Class →
CHEBI:24613
-
t292661
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 7617
- oboInOwl#hasDbXref
- Wikipedia:Octreotide
- core#notation
- CHEBI:7726
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 7617
- oboInOwl#hasDbXref
- Wikipedia:Octreotide
- oboInOwl#id
- CHEBI:7726
- generic_name
- Octreotide Hydrochloride
- brand_name
- Sandostatin LAR Depot
- brand_name_base
- Sandostatin LAR Depot
- dosage_form
- INJECTION, SOLUTION
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- product_ndc
- 41524-0007
- application_number
- ANDA077450
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_51060
- package_description
- 1 g in 1 BOTTLE (41524-0007-1)
- package_ndc
- 0078-0818-81
- core#notation
- CHEBI:7726
- rxcui
- 898607
- manufacturer_name
- GLENMARK PHARMACEUTICALS INC., USA
- active_ingredient_strength
- 200 ug/mL
- package_marketing_start_date
- 20050408
- pharm_class
- Somatostatin Receptor Agonists [MoA]
- active_ingredient_name
- OCTREOTIDE HYDROCHLORIDE
- unii
- 75R0U2568I
- spl_set_id
- f278f0d8-4062-420a-97c3-3a8b88253a08
- upc
- 0363323377007
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- listing_expiration_date
- 20241231
- route
- INTRAVENOUS
- marketing_start_date
- 20050408
- labeler_name
- BACHEM AMERICAS, INC.
- spl_id
- a7d30bd8-59b7-934a-e053-2a95a90af1d5
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6530
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_111843
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect34727
- owl#annotatedSource
- t293816
- owl#someValuesFrom
- t3708663